These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23127467)
1. β-Site amyloid precursor protein-cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau. Tsolakidou A; Alexopoulos P; Guo LH; Grimmer T; Westerteicher C; Kratzer M; Jiang M; Bujo H; Roselli F; Leante MR; Livrea P; Kurz A; Perneczky R Alzheimers Dement; 2013 Jul; 9(4):386-91. PubMed ID: 23127467 [TBL] [Abstract][Full Text] [Related]
2. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582 [TBL] [Abstract][Full Text] [Related]
4. Interrelations between CSF soluble AβPPβ, amyloid-β 1-42, SORL1, and tau levels in Alzheimer's disease. Alexopoulos P; Guo LH; Tsolakidou A; Kratzer M; Grimmer T; Westerteicher C; Jiang M; Bujo H; Diehl-Schmid J; Kurz A; Perneczky R J Alzheimers Dis; 2012; 28(3):543-52. PubMed ID: 22045485 [TBL] [Abstract][Full Text] [Related]
5. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease. Perneczky R; Alexopoulos P; Alzheimers Dement; 2014 Oct; 10(5 Suppl):S425-S429.e1. PubMed ID: 24239250 [TBL] [Abstract][Full Text] [Related]
7. Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease. Ewers M; Cheng X; Zhong Z; Nural HF; Walsh C; Meindl T; Teipel SJ; Buerger K; He P; Shen Y; Hampel H J Alzheimers Dis; 2011; 25(2):373-81. PubMed ID: 21460439 [TBL] [Abstract][Full Text] [Related]
8. Soluble BACE-1 Activity and sAβPPβ Concentrations in Alzheimer's Disease and Age-Matched Healthy Control Cerebrospinal Fluid from the Alzheimer's Disease Neuroimaging Initiative-1 Baseline Cohort. Savage MJ; Holder DJ; Wu G; Kaplow J; Siuciak JA; Potter WZ; J Alzheimers Dis; 2015; 46(2):431-40. PubMed ID: 25790831 [TBL] [Abstract][Full Text] [Related]
9. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Ma QL; Galasko DR; Ringman JM; Vinters HV; Edland SD; Pomakian J; Ubeda OJ; Rosario ER; Teter B; Frautschy SA; Cole GM Arch Neurol; 2009 Apr; 66(4):448-57. PubMed ID: 19364929 [TBL] [Abstract][Full Text] [Related]
10. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753 [TBL] [Abstract][Full Text] [Related]